Skip to main content
main-content

01.12.2016 | Case report | Ausgabe 1/2016 Open Access

Clinical Sarcoma Research 1/2016

Pazopanib: a novel treatment option for aggressive fibromatosis

Zeitschrift:
Clinical Sarcoma Research > Ausgabe 1/2016
Autoren:
Gulcan Bulut, Anil Ozluk, Atike Pınar Erdogan, Ruchan Uslu, Nevra Elmas, Burcak Karaca

Abstract

Background

Aggressive fibromatosis (AF), also known as desmoid tumor, is an uncommon soft tissue neoplasm. AF does not metastasize, but it is locally invasive and its propensity for recurrence after conservative resection is well documented. No effective cytotoxic treatment has been reported, hence there is a need for novel treatment strategies.

Case presentation

We present the case of an AF successfully treated with an oral tyrosine kinase inhibitor, pazopanib, with mild side effects. As far as we know, this is the first case of AF with complete response to pazopanib.

Conclusion

Pazopanib might be an effective treatment option for AF.
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2016

Clinical Sarcoma Research 1/2016 Zur Ausgabe

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise